Emergency room doctors are reaching for medicines that aren’t there after drug shortages jumped more than fivefold between 2008 and 2014. And experts say drug companies are to blame.
Manufacturing problems, few market incentives for the production of low-profit drugs and government inaction are leaving thousands of patients without essential medicine and creating complications usually seen only in the developing world, if ever.
In order to profit from high exchange rates on the international market, British pharmacists and wholesalers have limited the amount of certain drugs being sold to the National Health Service. The action has resulted in a shortage that has endangered patients with life-threatening conditions and inconvenienced many others.